Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.270
-0.040 (-3.05%)
Feb 27, 2026, 4:00 PM EST - Market closed
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $43.66 million as of February 27, 2026. Its market cap has decreased by -65.48% in one year.
Market Cap
43.66M
Enterprise Value
36.43M
1-Year Change
-65.48%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $43.66M, a decrease of -78.93%. That is a compound annual growth rate of -53.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 43.66M | -4.51% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 47.19M |
| NextCure | 46.53M |
| Impact BioMedical | 46.03M |
| Apollomics | 45.05M |
| Sensei Biotherapeutics | 44.00M |
| Lite Strategy | 43.27M |
| Aligos Therapeutics | 42.46M |
| Veru Inc. | 42.05M |